Thank you for downloading!

You may also view

CAR-T therapy products offer personalized, long-term therapeutic benefits for haematological malignancies. However, complexity of these products post many safety challenges.

Variations in the regulatory landscape and classification of cellular products across countries pose a major challenge for the sponsors. Get insights on how these products are categorized in the US & EU.

Our services for cell and gene therapy products